Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Beginning Cash Balance (2017 - 2022)

China Pharma Holdings (CPHI) has disclosed Beginning Cash Balance for 9 consecutive years, with -$4026.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Beginning Cash Balance fell 101.3% year-over-year to -$4026.0, compared with a TTM value of $223013.0 through Dec 2022, down 60.36%, and an annual FY2022 reading of $223013.0, down 60.36% over the prior year.
  • Beginning Cash Balance was -$4026.0 for Q4 2022 at China Pharma Holdings, up from -$4317.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $310783.0 in Q4 2021 and bottomed at -$4850.0 in Q2 2022.
  • Average Beginning Cash Balance over 4 years is $102821.2, with a median of $111691.0 recorded in 2019.
  • The sharpest move saw Beginning Cash Balance skyrocketed 172.36% in 2021, then tumbled 28880.0% in 2022.
  • Year by year, Beginning Cash Balance stood at $111691.0 in 2019, then grew by 2.16% to $114109.0 in 2020, then skyrocketed by 172.36% to $310783.0 in 2021, then plummeted by 101.3% to -$4026.0 in 2022.
  • Business Quant data shows Beginning Cash Balance for CPHI at -$4026.0 in Q4 2022, -$4317.0 in Q3 2022, and -$4850.0 in Q2 2022.